# Safety and Tolerability of ZE74-0282 in Healthy Volunteers

> **NCT07527221** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Eilean Therapeutics AU Pty Ltd** · enrollment: 40 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ZE74-0282-0001 or placebo

## Key facts

- **NCT ID:** NCT07527221
- **Lead sponsor:** Eilean Therapeutics AU Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-30
- **Primary completion:** 2026-11
- **Final completion:** 2027-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07527221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07527221, "Safety and Tolerability of ZE74-0282 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07527221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*